Last quarter (Q3 2024), ProMIS Neurosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, ProMIS Neurosciences's net income was $9.28M. See ProMIS Neurosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ ―	$ ―	$ ―	$ 8.14K	$ 1.23K
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 18.11M	$ 14.09M	$ 23.20M	$ 8.26M	$ 4.44M
Operating Income	$ -18.11M	$ -14.09M	$ -23.20M	$ -8.25M	$ -4.44M
Net Non Operating Interest Income Expense	$ -153.57K	$ -201.39K	$ -282.06K	$ 410.29K	$ -174.00
Other Income Expense	$ -17.70M	$ -1.08M	$ -5.42M	$ -577.83K	$ ―
Pretax Income	$ -563.35K	$ -13.21M	$ -18.06M	$ -9.24M	$ -4.44M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -563.35K	$ -13.21M	$ -18.06M	$ -9.79M	$ -4.44M
Basic EPS	$ -0.19	$ -1.07	$ -2.41	$ -108.00	$ ―
Diluted EPS	$ -0.19	$ -1.07	$ -2.41	$ -108.00	$ ―
Basic Average Shares	$ 88.97M	$ 12.29M	$ 7.50M	$ 96.43K	$ ―
Diluted Average Shares	$ 89.01M	$ 12.29M	$ 7.50M	$ 96.43K	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 18.11M	$ 14.09M	$ 23.20M	$ -8.26M	$ -4.44M
Net Income From Continuing And Discontinued Operation	$ -563.35K	$ -13.21M	$ -18.06M	$ -9.79M	$ -4.44M
Normalized Income	$ 355.29K	$ -9.71M	$ -13.28M	$ -6.85M	$ -3.26M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -409.78K	$ -13.01M	$ -17.78M	$ -9.37M	$ -4.44M
EBITDA	$ -391.76K	$ -12.99M	$ -17.53M	$ -9.33M	$ -4.43M

Currency in USD

ProMIS Neurosciences Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing